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Abstract  
 
Background Seasonal changes in cardiovascular disease risk factors may be due to exposure 
to seasonal environmental variables like temperature changes and acute infections, or 
seasonal behavioral patterns like changes in physical activity and diet. Investigating the 
seasonal pattern of cardiovascular risk factors should help determine the causes of the 
seasonal pattern in cardiovascular disease events. Few studies have investigated the seasonal 
variation in cardiovascular disease risk factors using repeated measurements from the same 
individual, which is important as the individual seasonal patterns may differ from the 
population seasonal pattern. 
Objectives To describe the seasonal variation in cardiovascular disease risk factors in 
repeated measurements in a population-based cohort. 
Methods We investigated the seasonal pattern in systolic and diastolic blood pressure, pulse, 
body mass index, body weight, total cholesterol, triglycerides, high-density lipoprotein 
cholesterol, c-reactive protein and fibrinogen. Measurements came from 38,835 participants 
from the Tromsø Study cohort examined in up to eight screenings from 1979 to 2008. 
Individual and population seasonal patterns were estimated using a cosinor model. 
Results All risk factors had a highly statistically significant seasonal pattern with peak time 
in winter, except from triglycerides (peak in late September) and c-reactive protein (peak in 
mid-June). The sizes of the seasonal variations were clinically modest. 
Conclusions Although we found highly statistically significant individual seasonal patterns 
for all risk factors, the sizes of the changes were modest in this sub-Arctic population, and 
may not be large enoughare unlikely to cause a seasonal pattern in cardiovascular events. 
 
Word count 243  
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Introduction 
Many studies have reported seasonal variation in cardiovascular disease (CVD) mortality 
(Healy 2003; The Eurowinter Group 1997) and coronary heart disease (CHD) events (Barnett 
et al. 2005), but the mechanisms underlying the seasonal pattern are not fully understood 
(Pell and Cobbe 1999). There are strong associations between short-term exposures to 
specific environmental and behavioral triggers and acute CVD events (Mittleman and 
Mostofsky 2011). Environmental exposures like temperature and acute infections, and 
behavioral factors like some types of physical activity and eating heavy meals have a 
seasonal pattern (Mittleman and Mostofsky 2011; Pell and Cobbe 1999). Such exposures may 
cause arrhythmia, acute ischemia, plaque disruption and thrombosis through changes in 
cardiac electric stability, vasoconstriction and coagulation leading to sudden cardiac death, 
stroke or myocardial infarction (Mittleman and Mostofsky 2011). Investigating the seasonal 
pattern of CVD risk factors should help determine the cause of the seasonal pattern in CVD 
events.  
 
An individual’s seasonal pattern may differ fromcan be quite different from the population 
seasonal pattern (Barnett and Dobson 2010). For example, cold winter weather may mean the 
highest level of blood pressure for the population, but not for those individuals who engage in 
winter sports. A large variation in individual seasonal patterns reduces the population 
seasonal pattern, meaning important changes in CVD risk factors might be missed.  Only a 
fFew studies investigating seasonal variation in CVD risk factors have been population-based 
(Barnett et al. 2007; Ulmer et al. 2004) or used repeated measurements in individuals (Ulmer 
et al. 2004; Ockene et al. 2004). The Tromsø Study, a population-based cohort study with 
repeated measurements of CVD risk factors for three decades of follow up, is a valuable data 
set for making a contribution to the scarce existing literature on individual seasonal patterns 
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of CVD risk factors. In this sub-Arctic population we have previously found a small increase 
in myocardial infarction incidence in the darkest winter months (Hopstock et al. 2011a) and 
after cold temperatures and heavy snowfall in the elderly (Hopstock et al. 2011b). To extend 
this work, the objective of tThis study extends this work by is to describinge the seasonal 
variation in CVD risk factors in repeated measurements in this population-based cohort. 
 
Methods 
 
Study population 
Tromsø, the regional centre of Northern Norway, is situated 400 km north of the Arctic 
Circle and has a dark winter season from mid-November to mid-January and a summer 
season with 24 hours daylight from mid-May to mid-July. The geographically dependent 
definition of meteorological season for the area of Tromsø’s seasons  isare: winter, (6 
November to 13 April),; spring (,14 April to 22 June),; summer, (23 June to 18 August); and 
autumn, (19 August to 5 November) (The Norwegian Meteorological Institute 2011a).  
 
The Tromsø Study is a single-center, population-based prospective cohort study. The cohort 
study design includes repeated health surveys to which total birth cohorts and random 
samples of the Tromsø population were invited (table 1). These surveys were conducted in 
1974 (Tromsø 1), 1979–80 (Tromsø 2), 1986–87 (Tromsø 3), 1994–95 (Tromsø 4), 2001 
(Tromsø 5) and in 2007–08 (Tromsø 6), by the University of Tromsø in cooperation with the 
National Health Screening Service. Response rates were between 66% and 85%. A total of 
40,051 men and women have participated in one or more surveys, and 15,157 have 
participated in three or more surveys. For the Tromsø 4–6 surveys a subset of participants 
were invited for a second and more extensive screening (Tromsø 4-2, 5-2 and 6-2) at which 
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further repeated CVD risk factor samples were taken. Details on the Tromsø Study sample 
and measurements are described elsewhere (Jacobsen et al. 2011). For this analysis we 
excluded subjects younger than 20 years (n=…), subjects who did not consent to research 
(n=222), and the first survey because of inconsistency differences in measurement methods 
compared with later surveys and because it only surveyed men (n=…), which left 38,835 
participants for inclusion. Approvals were obtained from the Regional Committee for 
Medical and Health Research Ethics, the Data Inspectorate and the Directorate of Health and 
Social Affairs. 
 
Cardiovascular disease risk factor measurements 
We examined the seasonal pattern in 10 CVD risk factors: systolic blood pressure (mmHg), 
diastolic blood pressure (mmHg), pulse (HR), body mass index (BMI) (kg/m2), body weight 
(kg), total cholesterol (mmol/L), triglycerides (mmol/L), high-density lipoprotein (HDL) 
cholesterol (mmol/L), c-reactive protein (CRP) (mg/L) and fibrinogen (g/L). Each survey 
used aA standardized examination protocol including physical examination, blood sampling 
and administration of questionnaires was followed at each survey, and the methods used for 
all five surveys were almost identical. Height and weight were measured with subjects 
wearing light clothing and no shoes. BMI was calculated as weight in kilograms divided by 
the square of height in meters. Participants were not requested to fast. Blood pressure was 
measured on the right upper arm after two/four minutes of rest with the participants in a 
sitting position, with an automatic device in all surveys except from Tromsø 2 where a 
mercury sphygmomanometer was used. To adjust for thise change in method, transformation 
of the recordings from the automatic devices were performed in accordance with previous 
validation methods (Lund-Larsen 1997).  Further details on data collection regarding blood 
pressure and blood samples have been described in detail elsewhere for Tromsø 2, 3 and 4 
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(Wilsgaard et al. 2001), for Tromsø 5 (…) and Tromsø 6 (…). The summer vacation meant f 
Fewer measurements were performed in late June and early August, and none in July, due to 
the summer vacation. 
 
Meteorological data 
Meteorological data were collected from the Meteorological Institute of Tromsø from the 
official webpage (The Norwegian Meteorological Institute, 2011b) for the period January 
1979 to December 2008.  
 
Statistical analysis 
All risk factors were approximately normally distributed except CRP and triglycerides which 
had a positively skewed distribution and so were log transformed prior to analyses. High 
CRP-levels are likely to be caused by acute infections or underlying inflammatory conditions, 
and some (Chiriboga et al. 2009) but not all (Rudnicka et al. 2007) studies investigating 
seasonal patterns in inflammatory markers have excluded measurements with CRP 
concentrations greater than 10 mg/L or self-reports of recent infections or surgical procedures 
(Schneider et al. 2008). Therefore, for the variables CRP and fibrinogen, separate analyses 
excluding CRP-levels greater than 10 mg/L were performed.  
 
We estimated the mean risk factor levels in each month by using a regression analysis with 
each risk factor as the dependent variable and month, sex and age (centred at age 50) as the 
independent variables. This gave the monthly risk factor means adjusted for age and sex. 
 
We assumed a sinusoidal seasonal pattern, and allowed this to vary at an individual level 
using a random effects model (random sinusoidal seasonal terms for each subject). We fitted 
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models with and without the random seasonal terms, and compared their fit using the Akaike 
Information Criterion (AIC) (Burnham and Anderson 2002). The model without the random 
seasonal terms (population model) assumes that every individual has the same seasonal 
pattern. Therefore a large improvement in model fit after adding the random seasonal terms 
(individual model) tells us that some individuals do vary from the population seasonal 
pattern. The sinusoidal seasonal pattern was fitted using cosine and sine terms based on the 
date of screening and assuming one cycle per year (known as a cosinor model). For each risk 
factor we: plotted the population seasonal pattern (population cosinor curve plots), used 
circular density plots of the estimated individual phases to show the (the size of the individual 
variation in the timing of the seasonal peak, i.e. the peak time point) and histograms of the 
individual amplitudes to show the variation in the height of the seasonal peak(difference from 
the individual mean, i.e. the size of the seasonal change, which gives the difference between 
peak and through time when multiplied by two). The histograms of individual amplitudes had 
skewed distributions, so we used the median and interquartile range (IQR) are reported in the 
tablesas summary statistics. We created a statistical tested for seasonality onat the population 
level by comparing the fit of the full population models with and without seasonal terms as a 
fixed effects using a chi-squared test. A, and on then individual level test of seasonality was 
made by comparing the full individual models with and without seasonal terms as a random 
effects for each subject. 
 
All models included a random intercept for each subject, to model constant differences 
between subjects (e.g., overweight versus underweight subjects). We used fixed effects for 
sex and age, to model the general increase in CVD risk factors with age and the differences 
between men and women. Survey number was included as a fixed effect to model CVD risk 
factor time trends. As a sensitivity analysis, all models Analysis wasere also stratified in 
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subgroups ofby sex. We tested for seasonality on the population level by comparing the full 
population model with and without seasonal terms as a fixed effect, and on the individual 
level by comparing the full individual model with and without seasonal terms as a random 
effect for each subject. 
 
Statistical analyses were performed using R version 2.13.2. (www.r-project.org) with using 
the lme4, circular and season packages. 
 
As season periods qualitatively and quantitatively vary with geographical area, the monthly 
mean of daily mean, minimum and maximum temperatures (degrees Celcius), sun hours 
(hours) and maximum snow cover on ground (centimeters) were included as descriptive data, 
to make comparison with seasons in other geographical areas possible. The meteorological 
data for the period January 1979 to December 2008 were calculated for the 30 year period as 
a whole. 
 
Results 
 
The monthly means of all risk factors for women estimated at age 50 are in table 2, together 
with monthly meteorological means. Calculations of tThe estimated individual phases (peak 
time point) and individual amplitudes (size of the seasonal change) adjusted for age and sex 
for all risk factors with model p-values for test of seasonality are in table 3. Figure 1 shows 
the relationship between the phase and the amplitude in the cosinor curve, exemplified by 
values for systolic blood pressure. Circular plots of the estimated phases for the individuals 
for all risk factors are shown in figure 2. Cosinor plots of the population seasonal patterns and 
Comment [AGB1]: Move to end of this 
section. 
Comment [AGB2]: There’s lots of good 
stuff in this section, but I think it needs 
some re-arrangement. 
Comment [AGB3]: Give  a following 
sentence with a quick comment on the most 
interesting things about the table. Maybe 
the shocking lack of sunlight! 
Comment [AGB4]: Same comment as 
above. 
Comment [AGB5]: Move this to the 
second result as it is a good introductory 
result to the concept of the seasonal pattern. 
Comment [AGB6]: Again I would 
expect more of a discussion of these results 
immediately after this sentence. 
11 
 
histograms of individual amplitudes for all risk factors are in the Supplemental Material, 
Figure 1. 
 
For blood lipids, the most evident seasonal pattern was for HDL cholesterol with the mean 
phase aton December 10, and a narrow phase IQR in the first part of December (table 3, 
figure 2). The narrow phase IQR indicates little individual variation from the population 
seasonal pattern. Total cholesterol had the phasepeaked in late November with a range 
corresponding from late autumn till the darkest winter period (table 3, figure 2), while 
triglycerides had the phasepeaked in mid-autumn (table 3, figure 2). Though highly 
statistically significant, the amplitudes of all blood lipids were small (table 3).  
 
Weight had theits phase in January with a wide IQR from late December to early May (table 
3, figure 2) and an amplitude of half a kg representing a maximum seasonal variation of one 
kg (table 3). BMI had a wide IQR from late December to early June (table 3). The estimated 
phase of BMI in early February (table 3) did not fit the data well (figure 2), the amplitude 
was clinically small and the seasonality test was only significant for the individual model 
(table 3). 
 
Individuals’ fibrinogen had a seasonal pattern with the phase in early spring, with a narrow 
IQR of less than a month. When excluding fibrinogen measurements that had CRP measured 
at the same date and where those CRP levels were > greater than 10 mg/L, the phase moved 
to late February and the width of the IQR became four times as large (table 3). The seasonal 
change in fibrinogen level was statistically significant, but clinically small (table 3). For CRP, 
analysis with and without CRP levels greater than> 10 mg/L had the phase in May and June 
respectively, with a wide IQR from late winter to late summer and early autumn, the 
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amplitude was small, and the seasonality test was only significant for the individual model 
(table 3).  
 
Systolic (figure 1) and diastolic blood pressure had their phases in late March and mid-
January, respectively. Diastolic blood pressure had a narrower phase IQR, indicating less 
individual variation around the population seasonal pattern. The pulse phase was in early 
winter. The seasonally increased levels of blood pressure and pulse were statistically 
significant, but the seasonal amplitudes were clinically small (table 3), with a seasonal 
variation of two mmHg for systolic and one mmHg for diastolic blood pressure, and less than 
one and half HR per minute for pulse. 
 
Results from the sex-stratified analysis were similar for all risk factors in both phase and 
amplitude (Supplemental Material, table 1 and 2) except for BMI, where the estimated phase 
was in late November for men and in late February for women. These are both winter months 
and the circular density plot had a similar pattern for the sexes (results not shown). Results 
from the seasonality tests were similar to those of the total materialafter stratifying by sex, 
except for weight that for women was only significancet infor the individual model, and for 
fibrinogen that for men was only significant in the individual model for all values and in the 
population model for non-pathological values (Supplemental Material, table 1 and 2). 
 
Discussion 
We found highly statistically significant individual seasonal patterns for all risk factors with 
peak time during winter for all risk factors, except for triglycerides which peaked in late 
September and CRP which peaked in which peaked in late September and mid-June 
respectively. The seasonal variations in all risk factors were clinically modest in size. 
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Blood lipids and body weight 
The sizes of the winter increase in total cholesterol and HDL cholesterol levels in the present 
study are similar to the findings from the SEASONS study from Massachusetts by Ockene 
and colleagues (Ockene et al. 2004) which consisted of 476 adults with four or more lipid 
measurements through a year. They found larger amplitude for triglycerides (Ockene et al. 
2004) compared with our study. A study from Ulmer and colleagues with repeated 
measurements among 149,650 adults in west-Austria reported larger winter versus summer 
levels changes in total cholesterol (Ulmer et al. 2004) compared with our findings. Larger 
winter versus summer values changes of both cholesterol and triglycerides levels compared 
with our study iswere also reported from a study with repeated measurements from 35 
survivors of acute myocardial infarction (AMI) and 47 healthy subjects from Slovenia by 
Mavri and colleagues (Mavri et al. 2001). They found lower levels of HDL cholesterol in 
winter compared to summer (Mavri et al. 2001), which also has been reported by a study with 
repeated measurements among 16 adults from Germany (Fröhlich et al. 1997).  
 
While the studies from Mavri (Mavri et al. 2001) and Ulmer (Ulmer et al. 2004) found larger 
seasonal variation in BMI than the currentour study, the size in winter increase in body 
weight in our study is similar to a later publication from the SEASONS Study, which also 
found a coinciding seasonal intake of caloric and fat, as well as reduced physical activity (Ma 
et al. 2006). This suggests that seasonal changes in diet and physical activity are associated 
with seasonal changes in weight/BMI and blood lipids. One study found elevated blood lipids 
and BMI in winter, but no coinciding seasonal pattern in diet and physical activity in repeated 
measurements in 147 adults in Germany (Blüher et al. 2001) suggesting that the seasonal 
rhythm in blood lipids are dependent on unknown endogenous factors or as a direct effect of 
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environmental factors. In the SEASONS study (Ockene et al. 2004) they found that a change 
in relative plasma volume due to hemodilution in summer and hemoconcentration in winter 
could be causing an apparent decrease in blood lipids during summer. 
 
Nutrition data was not included in our analysis and we can therefore only present suggestions 
for the seasonal changes seen in blood lipids and body weight. The short period of elevated 
winter levels of HDL-cholesterol may be the increased use intake of alcohol before and 
during the Christmas holiday time. It might also be explained by the use of cod liver oil, a 
traditional dietary supplement in Norway, often used only in the dark winter months (Brustad 
et al. 2004). In the Tromsø Study survey from 2001, 60% of the participants reported using 
cod liver oil all or parts ofthroughout the year (The Tromsø Study, 2011). Though 
controversy disagreements exists, recent review studies have shown a small increase of HDL 
cholesterol (Balk et al., 2006; Tziomalos et al. 2007), but a larger decrease in triglycerides 
(Balk et al. 2006; Saravanan et al. 2010; Tziomalos et al. 2007) with fish oil consumption, 
and no effect on total cholesterol (Balk et al. 2006). Despite a possible higher intake of fat 
during winter causing increased body weight in late winter, the possible effect of seasonal use 
of cod liver oil supplements and/or alcohol may be associated with our findings of a narrow 
phase of HDL cholesterol in mid-winter, not followed by a similar increase in triglycerides.  
 
Inflammatory markers 
For fibrinogen, we observed a small amplitude and narrow phase IQR when winter turns to 
spring, and a winter phase and wider phase IQR with similar amplitude when excluding 
observations of pathological CRP-levels. Though inconsistency exists (Stout et al. 1996; 
Crawford et al. 2003), several studies have shown that fibrinogen levels are higher in winter 
or cold temperatures than in summer or warm temperatures, but as for most other 
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investigations on seasonal patterns for CVD risk factors, these results are based on cross -
sectional studies (Rudnicka et al. 2007; van der Bom et al. 1997) in subgroups of elderly 
people (Stout and Crawford 1991; Woodhouse et al. 1994) or post myocardial infarction 
patients (Schneider et al. 2008), with seasonal variation amplitudes varying from 0.4 g/L 
(Rudnicka et al. 2007) to 1.26 g/L (Crawford et al. 2000), all larger than our finding. 
 
The seasonal pattern of fibrinogen did not coincide with the pattern of CRP. CRP peaked 
later in the spring and had a wide phase IQR, also when excluding pathological CRP levels. 
Several (Chiriboga et al. 2009; Schneider et al. 2008; Crawford et al. 2000), but not all 
(Fröhlich et al. 2002; Rogowski et al. 2005) studies have found higher CRP levels in winter 
or cold temperatures compared to summer or warm temperatures, with seasonal amplitudes of 
up to 30% increase reported by of Crawford and colleagues in their study of 24 healthy 
subjects aged over >75 years in Belfast measured each month through a year (Crawford et al. 
2000). The amplitude of CRP in the current study was close to but somewhat smaller than the 
9% increase reported from a publication from the SEASONS study (Chiriboga et al. 2009) 
with 534 adults with two or more measurements of CRP through a year.  
 
Both acute respiratory infections and cardiovascular events peak in winter, and acute 
infections are triggers of cardiovascular events (Mittleman and Mostofsky 2011; Corrales-
Medina et al. 2010). Higher levels of inflammatory markers like fibrinogen and CRP during 
winter are associated with colder temperatures (Schneider et al. 2008; Keatinge et al. 1984; 
Neild et al. 1994). Together with other risk factors increasing in winter or cold temperatures, 
such as increase in factor VII (Woodhouse et al. 1994; Crawford et al. 2003), platelet count 
(Keatinge et al. 1984; Fröhlich et al. 1997; Mavri et al. 2001), whole blood viscosity 
(Keatinge et al. 1984; Fröhlich et al. 1997) and decrease in plasma volume (Keatinge et al. 
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1984), this may lead to a hypercoagulate condition, which can increase the risk of a 
thrombotic event like sudden cardiac death, stroke or myocardial infarction (Mittleman and 
Mostofsky 2011). 
 
Hemodynamics 
Cold temperatures may increase hemodynamic factors like blood pressure and heart rate 
through activation of the sympathetic nervous system, which can lead to stroke, or 
myocardial infarction or sudden cardiac death through plaque rupture and thrombosis 
(Mittleman and Mostofsky 2011). Increased systolic (Barnett et al. 2007; Ulmer et al. 2004; 
Modesti et al. 2006; Keatinge et al. 1984; Woodhouse et al. 1993) and diastolic (Ulmer et al. 
2004; Woodhouse et al. 1993) blood pressure in winter or at cold temperatures has been 
previously reported. This is supported by our findings, as the period mid-November to mid-
April is considered meteorological winter time in Tromsø (table 2). Amplitudes for systolic 
blood pressure were similar to the findings from Ulmer (Ulmer et al. 2004) and the mean 
across populations from the 25 populations studied by Barnett and colleagues (Barnett et al. 
2007). Our Aseasonal change inmplitude for diastolic blood pressure was somewhat lower 
smaller than reported by Ulmer in Austria (Ulmer et al. 2004). Pulse levels peaked in early 
winter. Higher blood pressure in cold temperatures with no coinciding increase in pulse has 
been previously reported earlier (Modesti et al. 2006).  
 
Living in the High North 
Our findings of increased levels of CVD risk factors during the colder or darker winter period 
of the year were highly statistically significant, although small compared to reports from 
other studies. The clinical significance was modest and may not be large enough to cause a 
seasonal pattern in CVD events. 
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 The seasonal pattern of CVD events vary by geographical location, and populations living in 
colder climates show less seasonal variation of CHD mortality and morbidity (Healy 2003; 
Barnett et al. 2005; The Eurowinter Group 1997). To our knowledge, the only study 
investigating seasonal patterns in CVD risk factors comparing several populations is the 
study of seasonal variation in systolic blood pressure by Barnett (Barnett et al. 2007) who 
found less seasonal change in colder areas compared to warmer areas. The small seasonal 
increase in CVD risk factors in the present study coincides with our previous findings, as we 
found that in this sub-Arctic population, the increased risk of incident MI during the dark 
winter period of the year (Hopstock et al. 2011a) and after cold temperatures and heavy 
snowfall (Hopstock et al. 2011b) was small. This is probably due to the combination of high 
living standards and long-time climate-adaptive behavioral protection like wearing adequate 
clothing when being outdoors (The Eurowinter Group 1997; Makinen 2007) and having well-
insulated buildings with throughout-the-year warm and stable indoor temperatures (Healy 
2003; Bøkenes et al. 2011). 
 
Strengths 
The study is based on repeated measurements in a large population-based cohort of all ages, 
while the main body of knowledge in this area is based on cross-sectional studies. Cross-
sectional studies will always underestimate the size of the seasonal change in risk factors 
when there is individual variation in the timing of the peak (Barnett and Dobson 2010). This 
is because individual seasonal patterns can be cancelled out when examining the population 
average. For example, if half the population had a seasonal peak in winter and half in summer 
then the population seasonal pattern would look flat. This is exemplified in our results by the 
non-statistically significant population seasonal pattern in BMI and CRP, but a strongly 
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significant individual seasonal patterns.Examining individual seasonal variation is therefore 
the key for understanding the seasonal changes in risk. We used sinusoidal methods instead 
of dividing the year into seasons. 
 
Limitations 
There was a lack of measurements in July and few measurements in summer months 
compared with the rest of the year. A large number of subjects contributed only a single 
measurement, with varying number of measurements per risk factor. Using sinusoidal 
methods has the assumption of a symmetric peak and trough, and does not allow other 
possible seasonal patterns (e.g., a seasonal pattern with a sharp increase in autumn and steady 
decline in spring and summer). 
 
Conclusions 
In this sub-Arctic population we found highly statistically significant seasonal patterns with 
increases in CVD risk factors in colder or darker periods of the year. However tThe 
magnitude of the seasonal differences are likely  may be too small to contribute to acute CVD 
events.The relatively small changes are probably because the population of Tromsø are well 
adapted to cold weather.  
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Table 1. Year of examination, birth year, number of and participation percentage by gender. The 
Tromsø Study 1979–2008.  
Study Year of screening 
 
Gender 
 
Birth year 
 
Participants 
N (%)a 
Tromsø 2 1979–1980 
Men  1925–1959 8,477 (82) 
Women  1929–1959 8,144 (88) 
Tromsø 3 1986–1987 
Men  1925–1966 10,963 (78) 
Women  1930–1966 10,863 (85) 
Tromsø 4 
1994–1995 
 
Men  
1897–1969 
12,865 (74) 
Women  14,293 (79) 
Tromsø 4–2 
Men 
1910–1969 
3,397 (74) 
Women 4,568 (77) 
Tromsø 5 
2001 
Men  
1912–1971 
3,511 (76) 
Women  4,619 (81) 
Tromsø 5–2 
Men 
1912–1971 
2,447 (85) 
Women 3,492 (85) 
Tromsø 6 
2007–2008 
Men  
1920–1977 
6,054 (63) 
Women  6,930 (68) 
Tromsø 6–2 
Men 
1920–1969 
3,141 (92) 
Women 4,166 (92) 
        
a Percentage of eligible population    
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Table 2: Monthly mean values for cardiovascular risk factors for women, age centred on 50 years, and for meteorological data, Tromsø 1979–2008 
 
Month  SBP  
 
 
mmHg 
DBP  
 
 
mmHg 
Pulse  
 
 
HR 
BMI  
 
 
kg/m2 
Weight 
 
 
kg 
Total 
chol.  
 
mmol/L 
Trigly. 
  
 
mmol/L 
HDL 
 chol. 
 
mmol/L 
CRP 
 
 
mg/L 
Fibrin. 
 
 
g/L 
Daily 
mean 
temp 
(°C) 
Min 
temp 
 
(°C) 
Max 
temp 
 
(°C) 
Sun 
hours 
 
(h) 
Snow 
cover  
 
(cm) 
Jan 133.0 81.6 74.4 24.6  65.7 6.16 1.26 1.72 2.12 3.23 –3.6 –12.6 5.0 2 90 
Feb 133.1 81.7 75.2 24.6 65.4 6.08 1.25 1.66 2.29 3.39 –3.5 –12.6 4.6 32 104 
Mar  133.5 81.2 74.6 24.8 66.1 6.01 1.32 1.62 2.42 3.38 –2.2 –11.1 5.8 116 110 
Apr 133.2 80.8 72.9 25.1 67.1 5.96 1.32 1.63 2.21 3.35 0.8 –8.1 9.2 155 106 
May 132.7 80.4 72.9 25.0 67.0 5.90 1.28 1.61 2.37 3.40 5.0 –2.6 15.8 208 54 
Jun 130.3 80.2 72.5 25.4 68.1 5.76 1.25 1.59 2.30 3.26 9.3 1.6 21.3 229 2 
Jul           12.0 5.1 23.6 218 0 
Aug  131.5 80.1 72.5 24.9 65.2 5.95 1.28 1.67 2.38 3.24 11.0 11.0 22.0 168 0 
Sep  133.8 81.4 74.6 25.0 65.4 6.12 1.39 1.65 2.30 3.33 7.1 –0.4 16.3 96 2 
Oct  132.7 81.5 74.2 25.0 66.1 6.16 1.39 1.68 2.09 3.31 2.8 –5.3 10.9 51 23 
Nov  132.5 81.2 74.3 24.9 66.1 6.07 1.31 1.68 2.21 3.28 –0.7 –8.3 7.3 7 42 
Dec  132.3 81.1 73.7 24.7 65.9 6.00 1.29 1.68 2.21 3.21 –2.6 –11.0 6.1 0 61 
 
Footnote: Cardiovascular risk factors given for a women aged 50. Amplitude is in millimeter mercury (mmHg) for systolic (SBP) and diastolic blood pressure (DBP), heart 
rate per minute (HR) for pulse, kg/m2 for body mass index (BMI) calculated as weight in kilogram divided by the square of heights in meters, kilogram (kg) for weight, 
millimol per liter (mmol/L) for cholesterol, triglycerides and high-density lipoprotein (HDL) cholesterol, milligram per liter (mg/L) for c-reactive protein (CRP), gram per 
liter (g/L) for fibrinogen, degrees Celsius (°C) for daily mean, minimum (min) and maximum hours (h) temperatures (temp), hours for sun hours (h), centimeter (cm) for 
maximum snow cover on ground.  
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Table 3. Estimated phase reported as calendar days and calculated amplitude for cardiovascular risk 
factors, adjusted for sex and age, with median and IQR, and p-value for test of seasonality in bothat 
population and individual model.levels  
 
Variabele (nsubjects/observations) unit Phase Median (IQR; days) 
Amplitude 
Median (IQR) 
p-value 
Pop/Ind 
SBP (37998/91739) mmHg Mar 27 (Feb 6–Apr 25; 78) 1.03 (0.64–1.80) <0.001 
DBP (37998/91739) mmHg Jan 14 (Dec 13–Feb 2; 51) 0.54 (0.39–0.84) <0.001 
PULSE (34680/74998) HR Nov 12 (Oct 11–Dec 12; 62) 0.72 (0.56–1.01) <0.001 
BMI (37914/84532) kg/m2 Feb 8 (Dec 22–Jun 4; 162) 0.18 (0.10–0.31) 0.339/<0.001 
WEIGHT (37918/84545) kg Jan 19 (Dec 25–May 4; 130) 0.54 (0.30–0.88) <0.001 
CHOLESTEROL (37986/92641) mmol/L Nov 27 (Oct 26–Dec 23; 58) 0.13 (0.10–0.19) <0.001 
TRIGLYCERIDES log (37982/92626) % Sep 21 (Aug 25–Oct 8; 44) 3.0 (2.3–4.1) <0.001 
HDL (37971/92576) mmol/L Dec 10 (Dec 1–Dec 19; 18) 0.031 (0.029–0.037) <0.001 
CRP log (16292/31936) % May 23 (Mar 8–Aug 5; 150) 6.4 (3.3–11.2) 0.131/<0.001 
CRP if CRP<10 log (15909/30557) % Jun 18 (Apr 17–Sep 19; 124) 7.4 (3.9–12.1) 0.131/<0.001 
FIBRINOGEN (16450/25421) g/L Apr 29 (Apr 19–May 7; 18) 0.055 (0.050–0.063) <0.001 
FIBRINOGEN if CRP<10 (13884/16816) g/L Feb 22 (Jan 29–May 20; 81) 0.045 (0.027–0.079) 0.005/<0.001 
 
Footnote: Amplitude is in millimeter mercury (mmHg) for systolic (SBP) and diastolic blood pressure (DBP), 
heart rate per minute (HR) for pulse, kg/m2 for body mass index (BMI) (calculated as body weight in kilogram 
divided by the square of heights in meters), kilogram (kg) for body weight, millimol per liter (mmol/L) for 
cholesterol and high–density lipoprotein (HDL) cholesterol, percentage (%) for c–reactive protein (CRP) and 
triglycerides (log transformed) and gram per liter (g/L) for fibrinogen.   
Comment [AGB11]: I would split the p-
values into two columns. The table may 
have to be landscape. 
Comment [AGB12]: We should talk 
about how the results for BMI highlight the 
importance of testing for seasonality at an 
individual level, because there was no 
change at the population level. 
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Figure legends 
 
Figure 1.  
Cosinor plot of the population seasonal pattern for systolic blood pressure (mmHg) explaining 
amplitude (i.e. the size of the seasonal change from the individual mean) and phase (i.e. the 
peak time point). 
 
Figure 2.  
Circular plots of the individual phase (i.e. density plot of the estimated individual variation in 
the timing of the seasonal peak) for systolic (SBP) (mmHg) and diastolic blood pressure 
(DBP) (mmHg), pulse (HR), body mass index (BMI) (kg/m2), body weight (kg), total 
cholesterol (mmol/L), triglycerides log transformed (%), high–density lipoprotein (HDL) 
cholesterol (mmol/L), c–reactive protein (CRP) log transformed (%), CRP log transformed 
(%) for those with a CRP level < 10mg/L, fibrinogen (g/L) and fibrinogen (g/L) for those with 
a CRP level < 10mg/L, adjusted for sex and age. 
